1.Cytologic Features of ALK-Positive Pulmonary Adenocarcinoma.
Seung Yeon HA ; Jungsuk AHN ; Mee Sook ROH ; Joungho HAN ; Jae Jun LEE ; Boin LEE ; Jun YIM
Korean Journal of Pathology 2013;47(3):252-257
BACKGROUND: The aim of this study was to determine the cytologic features of anaplastic lymphoma kinase (ALK) expressing pulmonary adenocarcinoma. METHODS: We analyzed the cytopathological findings of 15 cases of endobronchial ultrasound guided aspiration and a case of bronchial washing. These cases were selected based on the histomorphology of ALK-rearranged lung adenocarcinoma. RESULTS: Cytology showed mucinous (81.3%) and hemorrhagic (50%) backgrounds. The cells were arranged in tubulopapillary or tubulocribriform patterns (93.8%), and clusters (56.3%) admixed with signet ring cell features (87.5%). The tumor cells were monotonous and uniform with vesicular nuclei and a small nucleolus. CONCLUSIONS: The characteristic findings were sheets showing a tubulopapillary or tubulocribriform appearance, with vesicular nuclei and a bland chromatin pattern (p<0.001). Scattered signet ring cells were helpful in suggesting ALK-positive adenocarcinoma (p<0.001).
Adenocarcinoma
;
Carcinoma, Non-Small-Cell Lung
;
Chromatin
;
Lung
;
Lymphoma
;
Mucins
;
Phosphotransferases
;
Receptor Protein-Tyrosine Kinases
2.KRAS Mutation Detection in Non-small Cell Lung Cancer Using a Peptide Nucleic Acid-Mediated Polymerase Chain Reaction Clamping Method and Comparative Validation with Next-Generation Sequencing.
Boram LEE ; Boin LEE ; Gangmin HAN ; Mi Jung KWON ; Joungho HAN ; Yoon La CHOI
Korean Journal of Pathology 2014;48(2):100-107
BACKGROUND: KRAS is one of commonly mutated genetic "drivers" in non-small cell lung cancers (NSCLCs). Recent studies indicate that patients with KRAS-mutated tumors do not benefit from adjuvant chemotherapy, so there is now a focus on targeting KRAS-mutated NSCLCs. A feasible mutation detection method is required in order to accurately test for KRAS status. METHODS: We compared direct Sanger sequencing and the peptide nucleic acid (PNA)-mediated polymerase chain reaction (PCR) clamping method in 134 NSCLCs and explored associations with clinicopathological factors. Next-generation sequencing (NGS) was used to validate the results of discordant cases. To increase the resolution of low-level somatic mutant molecules, PNA-mediated PCR clamping was used for mutant enrichment prior to NGS. RESULTS: Twenty-one (15.7%) cases were found to have the KRAS mutations using direct sequencing, with two additional cases by the PNA-mediated PCR clamping method. The frequencies of KRAS mutant alleles were 2% and 4%, respectively, using conventional NGS, increasing up to 90% and 89%, using mutant-enriched NGS. The KRAS mutation occurs more frequently in the tumors of smokers (p=.012) and in stage IV tumors (p=.032). CONCLUSIONS: Direct sequencing can accurately detect mutations, but, it is not always possible to obtain a tumor sample with sufficient volume. The PNA-mediated PCR clamping can rapidly provide results with sufficient sensitivity.
Alleles
;
Carcinoma, Non-Small-Cell Lung*
;
Chemotherapy, Adjuvant
;
Constriction*
;
Humans
;
Lung Neoplasms
;
Peptide Nucleic Acids
;
Polymerase Chain Reaction*
3.Micropapillary Mucinous Adenocarcinoma of the Lung: A Brief Case Report.
In Ho CHOI ; Boin LEE ; Joungho HAN ; Chin A YI ; Yong Soo CHOI ; Jin Seok AHN
Korean Journal of Pathology 2013;47(6):603-605
No abstract available.
Adenocarcinoma, Mucinous*
;
Lung*
;
Mucins*
4.High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma.
Boin LEE ; Sang Yun HA ; Dae Hyun SONG ; Hyun Woo LEE ; Soo Youn CHO ; Cheol Keun PARK
Gut and Liver 2014;8(6):662-668
BACKGROUND/AIMS: Ribonucleotide reductase subunit M2 (RRM2) catalyzes the production of deoxynucleotide triphosphates, which are necessary for DNA synthesis. RRM2 has been reported to play an active role in tumor progression, and elevated RRM2 levels have been correlated with poor prognosis for colorectal cancer patients. This study aimed to elucidate the prognostic significance of RRM2 protein expression in hepatocellular carcinoma after surgery. METHODS: RRM2 protein expression was evaluated using immunohistochemistry in tumor tissues from 259 hepatocellular carcinoma patients who underwent curative hepatectomy. RESULTS: High RRM2 expression was observed in 210 of 259 patients (81.1%) with hepatocellular carcinomas. High RRM2 expression was significantly associated with viral etiology (p=0.035) and liver cirrhosis (p=0.036). High RRM2 expression was correlated with early recurrence (p=0.004) but not with late recurrence (p=0.144). Logistic regression analysis revealed that high RRM2 expression (p=0.040) and intrahepatic metastasis (p<0.001) were independent predictors of early recurrence. High RRM2 expression unfavorably influenced both shorter recurrence-free survival (p=0.011) and shorter disease-specific survival (p=0.002) and was an independent predictor of shorter disease-specific survival (p=0.008). CONCLUSIONS: High RRM2 protein expression might be a useful marker for predicting early recurrence and may be a marker for poor prognosis of hepatocellular carcinoma after curative hepatectomy.
Adolescent
;
Adult
;
Aged
;
Carcinoma, Hepatocellular/*metabolism/surgery
;
Disease-Free Survival
;
Female
;
Hepatectomy
;
Humans
;
Immunohistochemistry
;
Liver Neoplasms/*metabolism/surgery
;
Logistic Models
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local/*metabolism
;
Prognosis
;
Ribonucleoside Diphosphate Reductase/*metabolism
;
Tumor Markers, Biological/*metabolism
;
Young Adult
5.Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes.
Hong Ki MIN ; Boin LEE ; Seung Ki KWOK ; Ji Hyeon JU ; Wan Uk KIM ; Young Min PARK ; Sung Hwan PARK
The Korean Journal of Internal Medicine 2015;30(4):521-530
BACKGROUND/AIMS: Allopurinol is a urate-lowering agent that is commonly used to prevent chemotherapy-related hyperuricemia. Allopurinol hypersensitivity syndrome (AHS) is a disorder involving multiple organs, which may be accompanied by cutaneous adverse reactions. We identified the characteristics and clinical outcomes of chemotherapy-associated AHS in patients with hematological malignancies. METHODS: This retrospective single-center study included 26 AHS patients (11 with and 15 without hematological malignancies) admitted to Seoul St. Mary's Hospital. AHS was defined using the criteria of Singer and Wallace. Comparisons were made using the Mann-Whitney U test and Fisher exact test as appropriate. RESULTS: In patients with a hematological malignancy and AHS, statistically significant differences were observed in terms of younger age at onset; shorter duration of exposure; higher starting and maintenance doses of allopurinol; lower incidence of eosinophilia, leukocytosis, and underlying renal insufficiency; and more frequent occurrence of fever compared to AHS patients without a hematological malignancy. Two AHS patients with a hematological malignancy were examined for human leukocyte antigen (HLA)-B typing, but neither patient harbored the HLA-B*5801 allele. All of the patients ceased allopurinol treatment, with most patients making a full recovery. Two patients in the study died; however, these deaths were unrelated to AHS. One patient developed serious sequelae of AHS that required hemodialysis. CONCLUSIONS: Physicians who prescribe allopurinol for the prevention of chemotherapy-related hyperuricemia should be aware of the unique risk of AHS, even in patients with hematological malignancies who do not have known risk factors for AHS. Novel urate-lowering agents should be considered alternative treatments.
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Allopurinol/*adverse effects
;
Antineoplastic Agents/*adverse effects
;
Comorbidity
;
Dose-Response Relationship, Drug
;
Drug Hypersensitivity Syndrome/diagnosis/drug therapy/*etiology
;
Female
;
Glucocorticoids/therapeutic use
;
Gout Suppressants/*adverse effects
;
Hematologic Neoplasms/*drug therapy
;
Humans
;
Hyperuricemia/chemically induced/diagnosis/*prevention & control
;
Male
;
Medical Records
;
Middle Aged
;
Republic of Korea
;
Retrospective Studies
;
Risk Factors
;
Treatment Outcome
;
Young Adult
6.A Group of Descending Glutamatergic Neurons Activated by Stress in Corticolimbic Regions Project to the Nucleus Accumbens.
Jin Young PARK ; So Young PARK ; Hyejin KWON ; Yumi SONG ; Boin YUN ; Yubin LEE ; Yeryung CHO ; Ahran JOO ; Pyung Lim HAN
Experimental Neurobiology 2018;27(5):387-396
The nucleus accumbens (NAc) is the major component of the ventral striatum that regulates stress-induced depression. The NAc receives dopaminergic inputs from the ventral tegmental area (VTA), and the role of VTA-NAc neurons in stress response has been recently characterized. The NAc also receives glutamatergic inputs from various forebrain structures including the prelimbic cortex (PL), basolateral amygdala (BLA), and ventral hippocampus (vHIP), whereas the role of those glutamatergic afferents in stress response remains underscored. In the present study, we investigated the extent to which descending glutamatergic neurons activated by stress in the PL, BLA, and vHIP project to the NAc. To specifically label the input neurons into the NAc, fluorescent-tagged cholera toxin subunit B (CTB), which can be used as a retrograde neuronal tracer, was injected into the NAc. After two weeks, the mice were placed under restraint for 1 h. Subsequent histological analyses indicated that CTB-positive cells were detected in 170~680 cells/mm² in the PL, BLA, and vHIP, and those CTB-positive cells were mostly glutamatergic. In the PL, BLA, and vHIP regions analyzed, stress-induced c-Fos expression was found in 20~100 cells/mm². Among the CTB-positive cells, 2.6% in the PL, 4.2% in the BLA, and 1.1% in the vHIP were co-labeled by c-Fos, whereas among c-Fos-positive cells, 7.7% in the PL, 19.8% in the BLA, and 8.5% in the vHIP were co-labeled with CTB. These results suggest that the NAc receives a significant but differing proportion of glutamatergic inputs from the PL, BLA, and vHIP in stress response.
Animals
;
Basolateral Nuclear Complex
;
Cholera Toxin
;
Depression
;
Hippocampus
;
Mice
;
Neurons*
;
Nucleus Accumbens*
;
Prosencephalon
;
Ventral Striatum
;
Ventral Tegmental Area